23andMe Holding Co - Warrants (16/06/2026) Profit Margin

23andMe Holding Co - Warrants (16/06/2026) posts a profit margin of -134.54% as of June 2025. That compares with -317.03% in the prior-year period — up 57.6% year over year. That is below the Healthcare sector average of 14.41%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, 23andMe Holding Co - Warrants (16/06/2026)'s profit margin was -317.03%. The latest reading is -134.54% — a 57.6% year-over-year increase (period ending June 2025). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 14.41% is typical. 23andMe Holding Co - Warrants (16/06/2026)'s -134.54% is lower that level. That is roughly 1033.4% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

23andMe Holding Co - Warrants (16/06/2026)'s profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -134.54% as of June 2025; use YoY and peer views to separate noise from signal.

Context for MEUSW's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 14.41%), and (3) consistency with growth and profitability. This page covers the first two; 23andMe Holding Co - Warrants (16/06/2026)'s other metric pages and overview cover the third.